Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pulse Biosciences CS
(NQ:
PLSE
)
16.82
+0.86 (+5.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pulse Biosciences CS
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
July 28, 2023
Via
Benzinga
Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
July 27, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
May 18, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Recap: Pulse Biosciences Q1 Earnings
May 11, 2023
Via
Benzinga
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
May 11, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
A Preview Of Pulse Biosciences's Earnings
March 29, 2023
Via
Benzinga
Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
May 11, 2023
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via
Benzinga
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
May 10, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
May 03, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces $65 Million Private Placement
May 01, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
April 27, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 31, 2023
Via
Benzinga
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
March 30, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
Latest Executive Changes In Marijuana Industry, New Appointments & Resignations
March 13, 2023
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari
Via
Benzinga
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
March 02, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
February 02, 2023
From
Pulse Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
Via
Benzinga
Pulse Biosciences Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Preview: Pulse Biosciences
November 09, 2022
Pulse Biosciences (NASDAQ:PLSE) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Pulse...
Via
Benzinga
Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
October 27, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 20, 2022
Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.